Abstract
The REMARK (Reporting Recommendations for Tumor Marker Prognostic Studies) guideline includes a checklist which aims to improve the reporting of these types of studies. Here, we expand on the REMARK checklist to enhance its use and effectiveness through better understanding of the intent of each item and why the information is important to report. Each checklist item of the REMARK guideline is explained in detail and accompanied by published examples of good reporting. The paper provides a comprehensive overview to educate on good reporting and provide a valuable reference of issues to consider when designing, conducting, and analyzing tumor marker studies and prognostic studies in medicine in general.
Keywords
ChecklistGuidelineMedicineMEDLINEElaborationMeta-analysisPsychologyPathologyBiologyCognitive psychology
Affiliated Institutions
Related Publications
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
Systematic reviews and meta-analyses are essential to summarize evidence relating to efficacy and safety of health care interventions accurately and reliably. The clarity and tr...
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
Systematic reviews and meta-analyses are essential to summarize evidence relating to efficacy and safety of health care interventions accurately and reliably. The clarity and tr...
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
Systematic reviews and meta-analyses are essential to summarise evidence relating to efficacy and safety of healthcare interventions accurately and reliably. The clarity and tra...
Reporting Randomized, Controlled Trials of Herbal Interventions: An Elaborated CONSORT Statement
Herbal medicinal products are widely used, vary greatly in content and quality, and are actively tested in randomized, controlled trials (RCTs). The authors' objective was to de...
PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation
Scoping reviews, a type of knowledge synthesis, follow a systematic approach to map evidence on a topic and identify main concepts, theories, sources, and knowledge gaps. Althou...
Publication Info
- Year
- 2012
- Type
- article
- Volume
- 9
- Issue
- 5
- Pages
- e1001216-e1001216
- Citations
- 1005
- Access
- Closed
External Links
Social Impact
Altmetric
PlumX Metrics
Social media, news, blog, policy document mentions
Citation Metrics
1005
OpenAlex
Cite This
Douglas G. Altman,
Lisa M. McShane,
Willi Sauerbrei
et al.
(2012).
Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): Explanation and Elaboration.
PLoS Medicine
, 9
(5)
, e1001216-e1001216.
https://doi.org/10.1371/journal.pmed.1001216
Identifiers
- DOI
- 10.1371/journal.pmed.1001216